MedTrace Logo

Impact of Interdental Brushing on the Evolution of Supra-gingival Bacterial Flora (BACTERIB)

NCT03714295 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2018-10-22

No results posted yet for this study

Summary

In France, two-thirds of adults over 35 years of age have at least a periodontal disease. The etiology is the accumulation of dental plaque, especially in interdental spaces. The cleaning of interdental spaces is particularly complex. This accumulation of dental plaque is at the origin of a modification of the bacterial flora in favor of periodontopathogenic bacteria. These pathogens can induce within the periodontal tissues an immune and inflammatory reaction that cause tissue degradation. The majority of studies focus on people over 30 years of age with gingivitis or periodontitis. However, young adults, in whom the initial or even reversible stages of periodontal disease are the most frequent, should be the preferred target of preventive measures for this pathology.

The main objective of this study is to quantify, in healthy patients, the evolution of the supragingival bacterial flora, in the interdental spaces, following the daily passage of brushes with the adapted diameter and single passage. The secondary objective is to evaluate the qualitative change in the bacterial flora (proportions of periodontal bacteria / commensal bacteria) following the interdental cleaning.

Conditions

  • Healthy

Interventions

OTHER

Use of interdental brushes

No intervention they just use interdental brushes as it should be done routinely

Sponsors & Collaborators

  • Claude Bernard University

    lead OTHER

Principal Investigators

  • Denis Bourgeois, Pr · University Lyon

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-01
Primary Completion
2015-04-15
Completion
2015-07-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03714295 on ClinicalTrials.gov